Capital Fund Management S.A. Biotechnology

Capital Fund Management S.A.

$33.5 Billion
Q1 2025

Stock List

Stock	Option Type	Value	Options Held	Last Trade	Trade History
MRNA Moderna, Inc.	CALL	$93.7 Million	3.3M	Q1 2025 Reduced 63.39%
MRNA Moderna, Inc.	PUT	$76.7 Million	2.7M	Q1 2025 Reduced 63.39%
NVO Novo Nordisk A S	CALL	$59.8 Million	861K	Q1 2025 Added 2.4%
REGN Regeneron Pharmaceuticals, Inc.	PUT	$50.5 Million	79.7K	Q1 2025 Added 62.95%
NVO Novo Nordisk A S	PUT	$34.5 Million	496K	Q1 2025 Added 2.4%
REGN Regeneron Pharmaceuticals, Inc.	CALL	$31.3 Million	49.4K	Q1 2025 Added 62.95%
BMRN Biomarin Pharmaceutical Inc	PUT	$6.29 Million	89K	Q1 2025 Reduced 22.62%
BMRN Biomarin Pharmaceutical Inc	CALL	$4.34 Million	61.4K	Q1 2025 Reduced 22.62%
TGTX Tg Therapeutics, Inc.	CALL	$1.63 Million	41.3K	Q3 2024 Reduced 66.12%
BPMC Blueprint Medicines Corp	PUT	$1.47 Million	16.6K	Q1 2025 Added 1.77%
NVAX Novavax Inc	CALL	$1.31 Million	205K	Q4 2024 Reduced 18.3%
CRSP Crispr Therapeutics Ag	CALL	$1.2 Million	35.3K	Q4 2024 Reduced 63.88%
NTLA Intellia Therapeutics, Inc.	CALL	$1.17 Million	164K	Q1 2025 New holding
VKTX Viking Therapeutics, Inc.	CALL	$852,000	35.3K	Q3 2024 Reduced 6.24%
TGTX Tg Therapeutics, Inc.	PUT	$824,000	20.9K	Q3 2024 Reduced 66.12%
VKTX Viking Therapeutics, Inc.	PUT	$514,000	21.3K	Q3 2024 Reduced 6.24%
NVAX Novavax Inc	PUT	$355,000	55.5K	Q4 2024 Reduced 18.3%
ADMA Adma Biologics, Inc.	CALL	$331,000	16.7K	N/A

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.